Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
12/1991
12/11/1991EP0460189A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
12/11/1991EP0460101A1 Immobilized cytokines
12/11/1991EP0235187B1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used
12/10/1991US5071961 Adsorption on alpha-hydroxyaminopropyl-modified adsorber, then elution
12/10/1991US5071960 Cleaning compounds; cosmetics, drugs
12/10/1991US5071959 Novel lymphokine for suppressing platelet activation
12/10/1991US5071956 Glycoproteins for treating vision defects, arthritis, cardiovascular disorders, tumors and rheumatic dieseases
12/10/1991US5071955 Octopeptide exhibiting antimypertensive activity
12/10/1991US5071909 Adsorption onto microporous membrane; deposition of polymer; entrapment in crosslinked network with or without bonding
12/10/1991US5071835 Ribonucleotide reductase inhibitors
12/10/1991US5071761 Dna sequence coding for human lymphoblastoid interferons
12/10/1991US5071529 Method and apparatus for bonding a polypeptide to a macromolecular support by photolytic catalysis
12/05/1991WO1991018927A1 Method for preparing interferon alpha-2 crystals
12/05/1991CA2084406A1 Method for preparing interferon alpha-2 crystals
12/04/1991EP0459564A2 Process for reduction of echinocandin type cyclohexapeptide compounds
12/04/1991EP0438402A4 Paralog affinity chromatography
12/04/1991EP0262191B1 Novel peptide derivatives
12/03/1991US5070188 Acylated epidermal growth factor
12/03/1991US5070021 Method of modifying oligosaccharide structure of tissue plasminogen activator
12/03/1991CA1292841C Peptide derivatives, their production and use
12/03/1991CA1292840C Sequencing of peptides
12/03/1991CA1292708C Monoclonal antibody against plasminogen-activating factor
12/02/1991WO1991019000A1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS
12/02/1991WO1991018866A2 1,4-diamino-2,3-dihydroxybutanes
12/02/1991CA2084087A1 1,4-diamino 2,3-dihydroxy butanes
12/02/1991CA2083399A1 Monoclonal antibody against the gag protein precursor p55 of human immunodeficiency virus
12/02/1991CA2043565A1 Enzyme and dna coding therefor
12/01/1991WO1991018919A1 Purification of human interleukin-4 from a secreted escherichia coli mutant
11/1991
11/30/1991CA2064710A1 Recombinant protein which binds to a complex viral antigen of hiv-1
11/30/1991CA2043378A1 Process for reduction of certain cyclohexapeptide compounds
11/28/1991WO1991018091A1 Stabilization of biological macromolecular substances and other organic compounds
11/28/1991WO1991018016A1 Biologically active peptides containing d-2-alkyltryptophan
11/28/1991WO1991018013A1 Synthetic senescent cell antigen
11/28/1991WO1991018009A1 A process for the purification of proteins
11/28/1991WO1991018008A1 Sequential c-terminal degradation of peptides and proteins
11/28/1991WO1991017765A1 Fibrin binding domain polypeptides and uses and methods of producing same
11/28/1991WO1991008478A3 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO)
11/28/1991CA2083150A1 Synthetic senescent cell antigen
11/28/1991CA2064066A1 Sequential c-terminal degradation of peptides and proteins
11/27/1991EP0458652A1 A process for the purification of proteins
11/27/1991EP0458072A1 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
11/27/1991EP0458064A2 Stabilization of somatotropins and other proteins by modification of cysteine residues
11/27/1991EP0457898A1 Proteinase inhibitory agents and methods for their use
11/27/1991EP0457875A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
11/27/1991EP0457837A1 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle
11/27/1991EP0138855B1 Method of determining antigenically active amino acid sequences
11/26/1991WO1991018921A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2
11/26/1991US5068351 Catalytic amidation in the presence of phosphinic anhydride, cyclization
11/26/1991US5068314 Lipopolysaccharide-binding polypeptide
11/26/1991US5068222 Polypeptides for treatment of cancer
11/26/1991CA2083688A1 Growth factor which inhibits the growth of cells overexpressing the human oncogene erbb-2
11/24/1991WO1991018107A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
11/24/1991CA2083598A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
11/21/1991EP0457738A1 Di-aminated derivative of SV-IV protein and method for the preparation thereof
11/21/1991EP0457701A1 Derivatives of endogenous mediators, their salts, process for preparation, application and compositions containing them
11/21/1991EP0457223A1 Stabilized fibroblast growth factor composition
11/21/1991EP0457195A2 Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same
11/21/1991EP0456727A1 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
11/21/1991EP0456662A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants
11/19/1991US5066787 Blood coagulation inhibiting proteins, processes for preparing them and their uses
11/19/1991US5066785 Using Novel Coupling Reagents
11/19/1991US5066784 Porous vinyl polymeric matrix filled with a physically- or chemically-bound reactive gel; high loadings; solid phase synthesis; chromatography; ion exchanging
11/19/1991US5066716 Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
11/19/1991US5066490 Protein crosslinking reagents cleavable within acidified intracellular vesicles
11/18/1991WO1991018096A1 Methods for trans-destabilization of specific proteins in vivo
11/18/1991WO1991017665A1 Proteinaceous fat substitute
11/18/1991CA2060655A1 Proteinaceous fat substitute
11/16/1991WO1991017823A1 Method and apparatus for biopolymer synthesis
11/16/1991CA2042569A1 Stabilized fgf composition
11/16/1991CA2042437A1 Immunologic enhancement of the somatogenic effect of somatotrophin with an antibody
11/16/1991CA2042295A1 Endogen mediator derivatives, salts thereof, process for their preparation, applications and compositions containing such
11/15/1991CA2042442A1 Peptide compound and its preparation
11/14/1991WO1991017439A1 Receptor assay for fk-506
11/14/1991WO1991017177A1 High affinity antibodies to small peptides
11/14/1991WO1991014706A3 Lectin affinity membranes and methods for using them
11/13/1991EP0456332A1 Purified interleukin 1 and DNA coding for interleukin 1 and their preparation, vectors containing such DNA and their preparation and use in transforming hosts to permit expression of interleukin 1
11/13/1991EP0456185A2 Renin inhibitors
11/13/1991EP0456138A2 Peptide-amidase and its application
11/13/1991EP0456039A2 Renin inhibiting amino acid derivatives
11/13/1991EP0455722A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them
11/13/1991EP0444129A4 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
11/13/1991EP0236385B1 A superoxide dismutase
11/13/1991CN1056105A Peptides with bradykinin-antagonistic action
11/12/1991US5064943 Basic PH to dissolve refractile bodies
11/12/1991US5064942 New protein tetranectin isolated from human blood
11/12/1991US5064940 Premixed dry reagent containing a protected amino acid and an activating agent for use in solid phase protein synthesis
11/12/1991US5064939 Cyclic gnrh antagonists
11/12/1991US5064767 Carboxyl-terminal protein sequencing method and kit
11/12/1991CA2041825A1 Renin inhibitors
11/12/1991CA1291999C Crystalline quinapril and a process for producing the same
11/11/1991WO1991016968A1 Membrane for isolating virus from solution
11/08/1991WO1991017173A1 Molecular recognition units
11/08/1991CA2082272A1 Molecular recognition units
11/08/1991CA2041875A1 Peptide amidase and the use thereof
11/06/1991EP0455133A2 Peptide antagonists of bradykinin
11/06/1991EP0454898A1 Glycosaminoglycan-modified protein, process for the production of this protein, use and pharmaceutical compositions containing the same
11/06/1991EP0454766A1 Polyvalent metal ion-containing antibody combining site catalysts
11/06/1991EP0454726A1 Hindered linking agents and methods
11/06/1991EP0203107B1 Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells
11/06/1991CA2041817A1 Amino acid derivatives
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 518